Baird’s Avanos Medical AVNS Stock Holding History

Baird’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.8M	Buy	36,496 +21,335	+141%	+$988K	0.02%	573
2014 Q4	$689K	Buy	+15,161	New	+$596K	0.01%	843

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Baird's AVNS Position: Q1 2015 in Review

Baird increased its Avanos Medical (AVNS) stake by 141% in Q1 2015, buying an estimated $988K and bringing the position to 36,496 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #573.

Baird first reported a position in AVNS in Q4 2014 and has held it in 2 quarters since. 447 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

Baird held 36,496 shares of Avanos Medical worth $1.8M as of Q1 2015.
Baird bought 21,335 Avanos Medical shares in Q1 2015, an estimated $988K.
Avanos Medical made up 0.02% of Baird's portfolio in Q1 2015, its #573 holding.
Baird first reported a position in Avanos Medical in Q4 2014 and has held it in 2 quarters since.
447 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.